Nuveen Asset Management, LLC Ngm Biopharmaceuticals Inc Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Ngm Biopharmaceuticals Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 94,178 shares of NGM stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

94,178

Previous 624,532 84.92%

Holding current value

Previous $537,000 72.25%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$1.17 - $1.92 $620,514 - $1.02 Million	-530,354 Reduced 84.92%	94,178 $149,000
Q4 2023 Feb 14, 2024	BUY	$0.6 - $1.31 $445 - $972	742 Added 0.12%	624,532 $537,000
Q3 2023 Nov 14, 2023	SELL	$1.05 - $3.37 $165,424 - $530,933	-157,547 Reduced 20.16%	623,790 $667,000
Q2 2023 Aug 14, 2023	BUY	$2.44 - $4.53 $30,385 - $56,412	12,453 Added 1.62%	781,337 $2.02 Million
Q1 2023 May 15, 2023	BUY	$3.72 - $5.4 $41,407 - $60,107	11,131 Added 1.47%	768,884 $3.14 Million

Q4 2022 Feb 14, 2023	BUY	$3.41 - $12.93 $64,595 - $244,932	18,943 Added 2.56%	757,753 $3.8 Million
Q3 2022 Nov 14, 2022	BUY	$12.59 - $17.67 $2.56 Million - $3.59 Million	203,372 Added 37.98%	738,810 $9.66 Million
Q2 2022 Aug 15, 2022	BUY	$10.58 - $17.5 $3.05 Million - $5.05 Million	288,412 Added 116.75%	535,438 $6.86 Million
Q1 2022 May 16, 2022	SELL	$13.81 - $18.6 $120,616 - $162,452	-8,734 Reduced 3.41%	247,026 $3.75 Million
Q4 2021 Feb 14, 2022	BUY	$17.26 - $22.02 $1.38 Million - $1.76 Million	79,824 Added 45.37%	255,760 $4.53 Million
Q3 2021 Nov 12, 2021	BUY	$20.15 - $26.19 $1.04 Million - $1.36 Million	51,773 Added 41.7%	175,936 $4.05 Million
Q2 2021 Aug 16, 2021	SELL	$15.06 - $30.03 $730,605 - $1.46 Million	-48,513 Reduced 28.09%	124,163 $2.45 Million
Q1 2021 May 17, 2021	BUY	$24.99 - $31.93 $1.82 Million - $2.32 Million	72,696 Added 72.71%	172,676 $5.02 Million
Q4 2020 Feb 16, 2021	BUY	$16.21 - $31.44 $99,578 - $193,135	6,143 Added 6.55%	99,980 $3.03 Million
Q3 2020 Nov 16, 2020	SELL	$15.59 - $19.97 $285,000 - $365,071	-18,281 Reduced 16.31%	93,837 $1.49 Million
Q2 2020 Aug 14, 2020	SELL	$11.97 - $23.47 $27,770 - $54,450	-2,320 Reduced 2.03%	112,118 $2.21 Million
Q1 2020 May 14, 2020	SELL	$10.0 - $19.51 $1.08 Million - $2.11 Million	-108,031 Reduced 48.56%	114,438 $1.41 Million
Q4 2019 Feb 14, 2020	BUY	$9.97 - $20.28 $1.98 Million - $4.03 Million	198,635 Added 833.41%	222,469 $4.11 Million
Q3 2019 Nov 14, 2019	BUY	$13.09 - $18.19 $180,877 - $251,349	13,818 Added 137.96%	23,834 $330,000
Q2 2019 Aug 15, 2019	BUY	$12.56 - $16.6 $125,800 - $166,265	10,016 New	10,016 $147,000

Others Institutions Holding NGM

# of Institutions

Shares Held

36.9M

Call Options Held

1.1K

Put Options Held

200

View Full List

About NGM BIOPHARMACEUTICALS INC

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

More about NGM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Ngm Biopharmaceuticals Inc Transaction History